Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1965 1
1974 1
1975 2
1976 1
1977 1
1978 2
1979 1
1990 1
1994 2
1995 1
1997 1
1999 1
2000 1
2008 1
2014 1
2015 1
2016 1
2017 4
2019 4
2020 5
2021 7
2022 4
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

40 results

Results by year

Filters applied: . Clear all
Page 1
Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes.
Marso SP, Daniels GH, Brown-Frandsen K, Kristensen P, Mann JF, Nauck MA, Nissen SE, Pocock S, Poulter NR, Ravn LS, Steinberg WM, Stockner M, Zinman B, Bergenstal RM, Buse JB; LEADER Steering Committee; LEADER Trial Investigators. Marso SP, et al. N Engl J Med. 2016 Jul 28;375(4):311-22. doi: 10.1056/NEJMoa1603827. Epub 2016 Jun 13. N Engl J Med. 2016. PMID: 27295427 Free PMC article. Clinical Trial.
Liraglutide and Renal Outcomes in Type 2 Diabetes.
Mann JFE, Ørsted DD, Brown-Frandsen K, Marso SP, Poulter NR, Rasmussen S, Tornøe K, Zinman B, Buse JB; LEADER Steering Committee and Investigators. Mann JFE, et al. N Engl J Med. 2017 Aug 31;377(9):839-848. doi: 10.1056/NEJMoa1616011. N Engl J Med. 2017. PMID: 28854085 Free article. Clinical Trial.
Efficacy and safety of oral semaglutide in patients with type 2 diabetes and moderate renal impairment (PIONEER 5): a placebo-controlled, randomised, phase 3a trial.
Mosenzon O, Blicher TM, Rosenlund S, Eriksson JW, Heller S, Hels OH, Pratley R, Sathyapalan T, Desouza C; PIONEER 5 Investigators. Mosenzon O, et al. Lancet Diabetes Endocrinol. 2019 Jul;7(7):515-527. doi: 10.1016/S2213-8587(19)30192-5. Epub 2019 Jun 9. Lancet Diabetes Endocrinol. 2019. PMID: 31189517 Free article. Clinical Trial.
[Charcot's arthropathy].
Christensen TM, Yderstraede K, Ejskjaer N, Jakobsen PE, Kjaer IL, Levin S, Nielsen AL, Svendsen OL, Holstein P. Christensen TM, et al. Among authors: jakobsen pe. Ugeskr Laeger. 2008 Aug 11;170(33):2440-5. Ugeskr Laeger. 2008. PMID: 18761826 Review. Danish.
Diabetic Neuropathy Influences Control of Spinal Mechanisms.
Nedergaard RB, Nissen TD, Mørch CD, Meldgaard T, Juhl AH, Jakobsen PE, Karmisholt J, Brock B, Drewes AM, Brock C. Nedergaard RB, et al. Among authors: jakobsen pe. J Clin Neurophysiol. 2021 Jul 1;38(4):299-305. doi: 10.1097/WNP.0000000000000691. J Clin Neurophysiol. 2021. PMID: 32501945
Reduced Thalamic Volume and Metabolites in Type 1 Diabetes with Polyneuropathy.
Hansen TM, Frøkjær JB, Selvarajah D, Muthulingam JA, Tesfaye S, Juhl A, Drewes AM, Jakobsen PE, Karmisholt J, Brock B, Brock C. Hansen TM, et al. Among authors: jakobsen pe. Exp Clin Endocrinol Diabetes. 2022 May;130(5):327-334. doi: 10.1055/a-1347-2579. Epub 2021 Feb 1. Exp Clin Endocrinol Diabetes. 2022. PMID: 33524993
40 results